跳至主要内容
临床试验/CTRI/2015/06/005849
CTRI/2015/06/005849已完成Phase 3 4

Levetiracetam vs Phenobarbitone in acute neonatal seizures - a Randomised Control Trial

Dr Nikhil D Kulkarni1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2013年1月10日最近更新:

试验速览

阶段
Phase 3 4
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Recurrence of seizure and need for another anticonvulsant.

研究概览

简要总结

Hypothesis: In acute management of neonatal seizures, intravenous Levetiracetam 30 mg/kg/dose as against 20 mg/kg/dose of Phenobarbitone achieves 50% more seizure control clinically at 7 days as compared to Phenobarbitone.

Purpose: To find a better, safe and effective anticonvulsant in the management of acute neonatal seizures.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
0.00 Day(s) 至 1.00 Month(s)(—)
性别
All

入选标准

  • > 1000 g birth weight and > 28 weeks gestation.
  • all term neonates.

排除标准

  • hypoglycemic seizures 2)neonates treated with anticonvulsants prior to admission.

结局指标

主要结局

Recurrence of seizure and need for another anticonvulsant.

时间窗: Immediately on the day of seizure i.e. within 24 hours.

次要结局

  • Monitoring of adverse drug reactions of each drug like Phenobarbitone toxicity, mortality and neurodevelopmental follow up in follow up clinic.(After treatment of seizures within 7 days and on followup at 1 month, 3 months,6 months, 9 months, 12 months, 15 months, 18 months and 24 months.)

研究者

发起方
Dr Nikhil D Kulkarni
申办方类型
Other [self sponsored]

研究点 (1)

Loading locations...

相似试验